Ikram Shah Ismail

2.6k total citations · 1 hit paper
68 papers, 1.9k citations indexed

About

Ikram Shah Ismail is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Ikram Shah Ismail has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Ikram Shah Ismail's work include Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Education (7 papers) and Diabetes Management and Research (7 papers). Ikram Shah Ismail is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Education (7 papers) and Diabetes Management and Research (7 papers). Ikram Shah Ismail collaborates with scholars based in Malaysia, United Kingdom and Yemen. Ikram Shah Ismail's co-authors include M. F. Scanlon, Rajes Qvist, G. Piscitelli, Jonathan Webster, Carlo Ferrari, Anna Polli, Sher Zaman Safi, Sekaran Muniandy, Kalaivani Batumalaie and Khaled Abdul‐Aziz Ahmed and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ikram Shah Ismail

67 papers receiving 1.8k citations

Hit Papers

A Comparison of Cabergoline and Bromocriptine in the Trea... 1994 2026 2004 2015 1994 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ikram Shah Ismail Malaysia 23 1.0k 482 324 218 174 68 1.9k
Salvatore Caputo Italy 23 899 0.9× 448 0.9× 488 1.5× 198 0.9× 80 0.5× 57 2.1k
Dorota Zozulińska‐Ziółkiewicz Poland 23 763 0.7× 365 0.8× 205 0.6× 173 0.8× 86 0.5× 187 1.7k
Emin Özbek Türkiye 27 405 0.4× 348 0.7× 449 1.4× 167 0.8× 199 1.1× 126 2.6k
Yi‐Jen Hung Taiwan 26 464 0.4× 284 0.6× 467 1.4× 305 1.4× 90 0.5× 114 1.9k
Yu‐Bae Ahn South Korea 34 1.4k 1.4× 872 1.8× 468 1.4× 381 1.7× 86 0.5× 115 2.9k
Renzo Navalesi Italy 28 1.1k 1.1× 791 1.6× 540 1.7× 159 0.7× 113 0.6× 135 2.6k
Matthew D. Campbell United Kingdom 25 685 0.7× 281 0.6× 519 1.6× 125 0.6× 176 1.0× 72 1.9k
Ottavio Giampietro Italy 24 567 0.5× 325 0.7× 329 1.0× 153 0.7× 125 0.7× 144 2.0k
Richard Donnelly United Kingdom 18 600 0.6× 396 0.8× 297 0.9× 182 0.8× 49 0.3× 41 1.6k
Andrzej S. Januszewski Australia 25 580 0.6× 192 0.4× 542 1.7× 219 1.0× 153 0.9× 84 2.2k

Countries citing papers authored by Ikram Shah Ismail

Since Specialization
Citations

This map shows the geographic impact of Ikram Shah Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikram Shah Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikram Shah Ismail more than expected).

Fields of papers citing papers by Ikram Shah Ismail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikram Shah Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikram Shah Ismail. The network helps show where Ikram Shah Ismail may publish in the future.

Co-authorship network of co-authors of Ikram Shah Ismail

This figure shows the co-authorship network connecting the top 25 collaborators of Ikram Shah Ismail. A scholar is included among the top collaborators of Ikram Shah Ismail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikram Shah Ismail. Ikram Shah Ismail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safi, Sher Zaman, Humaira Shah, Abid Ali, et al.. (2022). Mechanisms of β-adrenergic receptors agonists in mediating pro and anti-apoptotic pathways in hyperglycemic Müller cells. Molecular Biology Reports. 49(10). 9473–9480. 9 indexed citations
2.
Ismail, Ikram Shah, et al.. (2020). The Effect of Low pH Level on Zebrafish (Danio Rerio) Reproductive Performance. 2(1). 15–20. 1 indexed citations
3.
Safi, Sher Zaman, et al.. (2018). Beta Adrenergic Receptors Stimulation Attenuates Phosphorylation of NF-κB and IκBα in Hyperglycemic Endothelial Cells. Cellular Physiology and Biochemistry. 51(3). 1429–1436. 11 indexed citations
4.
Safi, Sher Zaman, Mohammad Reza Sazegar, Rajes Qvist, et al.. (2016). Adsorption of amoxicillin on surfactant modified zeolites and their antibacterial activity. Research Journal of Biotechnology. 11(9). 75–78. 10 indexed citations
5.
Perumal, Vikneswari, Azizah Abdul Hamid, Amin Ismail, et al.. (2015). Evaluation of antidiabetic properties of Momordica charantia in streptozotocin induced diabetic rats using metabolomics approach. International Food Research Journal. 22(3). 1298–1306. 14 indexed citations
6.
Batumalaie, Kalaivani, et al.. (2013). The antioxidant effect of the Malaysian Gelam honey on pancreatic hamster cells cultured under hyperglycemic conditions. Clinical and Experimental Medicine. 14(2). 185–195. 22 indexed citations
7.
Safi, Sher Zaman, Rajes Qvist, Sailesh Kumar, & Ikram Shah Ismail. (2013). Molecular mechanisms of Diabetic Retinopathy, general preventive strategies and novel therapeutic targets. Experimental and Clinical Endocrinology & Diabetes. 121(3). 2 indexed citations
8.
Khir, Amir Sharifuddin Md, Aziz Al-Safi Ismail, Ikram Shah Ismail, et al.. (2012). Predictors of ischaemic heart disease in a Malaysian population with the metabolic syndrome. Diabetic Medicine. 29(11). 1378–1384. 3 indexed citations
9.
Mohamud, Wan Nazaimoon Wan, Amir Sharifuddin Md Khir, Ikram Shah Ismail, et al.. (2012). Prevalence of metabolic syndrome and its risk factors in adult Malaysians: Results of a nationwide survey. Diabetes Research and Clinical Practice. 96(1). 91–97. 108 indexed citations
10.
Saif-Ali, Riyadh, et al.. (2012). IGF2BP2 Alternative Variants Associated with Glutamic Acid Decarboxylase Antibodies Negative Diabetes in Malaysian Subjects. PLoS ONE. 7(9). e45573–e45573. 7 indexed citations
11.
Bebakar, Wan Mohamad Wan, Amir Sharifuddin Md Khir, Ikram Shah Ismail, et al.. (2011). Clustering of metabolic syndrome factors in Malaysian population: Asian Criteria revisited. International journal of collaborative research on internal medicine & public health. 3(8). 655–664. 1 indexed citations
12.
Ahmed, Khaled Abdul‐Aziz, et al.. (2011). Evaluation of N-(carboxymethyl)lysine and lipid peroxidation in multiethnic Malaysian subjects with type 2 diabetes mellitus. Scientific Research and Essays. 6(9). 1957–1962. 5 indexed citations
13.
Saif-Ali, Riyadh, et al.. (2011). Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects. Journal of Clinical Biochemistry and Nutrition. 50(3). 184–189. 10 indexed citations
14.
Mustafa, Norlaila, Amir Sharifuddin Md Khir, Ikram Shah Ismail, et al.. (2011). Prevalence of Abnormal Glucose Tolerance and Risk Factors in Urban and Rural Malaysia. Diabetes Care. 34(6). 1362–1364. 21 indexed citations
15.
Ahmed, Khaled Abdul‐Aziz, Sekaran Muniandy, & Ikram Shah Ismail. (2010). Type 2 Diabetes and Vascular Complications: A pathophysiologic view. Biomedical Research-tokyo. 21(2). 0. 31 indexed citations
16.
Muniandy, Sekaran, Rajes Qvist, Karuthan Chinna, Ikram Shah Ismail, & Kaviarasan Subramanian. (2010). Is F2-isoprostane a biological marker for the early onset of type 2 diabetes mellitus?. International Journal of Diabetes in Developing Countries. 30(3). 167–167. 3 indexed citations
17.
Yaiw, Koon-Chu, et al.. (2008). Quantification of Zonula Occludens-1 mRNA expression in cultu-red bovine retinal endothelial cells, using SYBR green real-time PCR. Biomedical Research-tokyo. 19(2). 0. 2 indexed citations
18.
Owens, David R., Stephen D. Luzio, Ikram Shah Ismail, & Thomas A. Bayer. (2000). Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.. Diabetes Care. 23(4). 518–523. 48 indexed citations
19.
Lewis, B. M., Ikram Shah Ismail, Basil Issa, J R Peters, & M. F. Scanlon. (1996). Desensitisation of somatostatin, TRH and GHRH responses to glucose in the diabetic (Goto-Kakizaki) rat hypothalamus. Journal of Endocrinology. 151(1). 13–17. 13 indexed citations
20.
Webster, Jonathan, G. Piscitelli, A D’Alberton, et al.. (1993). The efficacy and tolerability of long‐term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. Clinical Endocrinology. 39(3). 323–329. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026